Stay updated with breaking news from Anges Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The artificial blood vessels market is anticipated to grow significantly in the coming years, driven by advancements in biotechnology and the rising prevalence of cardiovascular diseases. With
The artificial blood vessels market is anticipated to grow significantly in the coming years, driven by advancements in biotechnology and the rising prevalence...
May 29, 2024 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO Tie2 receptor agonist ,co-development...
The surge in demand for angioplasty balloons and stents is mainly driven by the increasing prevalence of cardiovascular diseases (CVDs), the growing preference...
CAMBRIDGE, United Kingdom and NEW YORK, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Artios Pharma Limited (“Artios”), clinical-stage biotech company led b...